Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
289 Leser
Artikel bewerten:
(1)

Softeon Ranked Amongst the Five Highest Scoring Vendors for Level 3 Through Level 5 Warehouse Operations Use Cases in 2024 Gartner Critical Capabilities Report

Finanznachrichten News

RESTON, VA / ACCESSWIRE / August 9, 2024 / Softeon, the only tier-1 warehouse management system (WMS) provider focused on optimizing warehouse and fulfillment performance to increase operational efficiency, is listed in the Gartner Critical Capabilities for WMS for Level 3, Level 4 and Level 5 Warehouse Operations Use Cases.

Gartner, whose 5-level model ranges from Level 1, representing the least complex warehouse operations, to Level 5, signifying the most complex operations, recommends that companies "target the solutions best suited to your distinctive WMS use cases by developing a right-fit shortlist of vendors and solutions, using this research in combination with its companion WMS Magic Quadrant."

Softeon, which provides a unified platform offering both a Warehouse Management System (WMS) and a Warehouse Execution System (WES) to support automated and non-automated operations, scored 2.34/5.0 for Level 1, 2.73/5.0 for Level 2/5.0, and 3.38/5.0 for Level 5 Warehouse Operations Use Cases in the 2024 Gartner Critical Capabilities Report.

We belive Softeon's scores for Level 3 through Level 5 Warehouse Operations signify its ability to support the most complex warehouse operations and are driven by its robust core WMS capabilities, extended WMS features (such as a billing management system that can be deployed independently), and additional SCE capabilities like WES, DOM, returns management, and direct store delivery, all available on a unified platform.

"Softeon has long provided solutions for our customers' largest, most sophisticated, and highly automated facilities," says Jim Hoefflin, CEO of Softeon. "We feel our consistent placement in the Critical Capabilities Report recognizes our strengths and challenges. We have the solutions and approach for helping any organization looking to solve their most challenging problems regarding complex order flows, varying automation sub-systems, and multi-system integrations."

Softeon's WMS drives the logistics performance of numerous top companies, including Brooks, Casey's, DB Schenker, Denso, Saddle Creek Logistics, Sears Home Services, Sony DADC, Suncast, UPS Supply Chain Solutions, UPS Healthcare, and many others.

As a WMS industry capabilities leader, Softeon remains committed to empowering the world's most complex, highly automated warehouses. We think recognition in the Gartner Critical Capabilities Report for seven years in a row demonstrates Softeon's ability to unlock the full potential of its customer's supply chains through innovative capabilities and solutions.

Download your complimentary copy of the Gartner Critical Capabilities Report to gain valuable insights on Softeon and each recognized WMS vendor.

ABOUT SOFTEON

Softeon is a WMS provider focused exclusively on optimizing warehouse and fulfillment operations. For over two decades now, we have been helping our customers succeed. Investing in R&D enables us to develop software to solve the most complex warehouse challenges. Softeon is laser-focused on customer results, with a 100% track record of deployment success. We believe warehouse leaders shouldn't have to settle for a one-size-fits-all all approach to technology. For more information, please visit www.softeon.com.

Gartner, Critical Capabilities for Warehouse Management Systems, Simon Tunstall, Dwight Klappich, Rishabh Narang, Federica Stufano, 6 August 2024. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Contact Information:

Michael Catalino
Director, Public Relations and Analyst Relations
mcatalino@softeon.com
2155899471

SOURCE: Softeon

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.